英派斯(002899) - 2023 Q3 - 季度财报

Financial Performance - Revenue for Q3 2023 reached ¥263,405,635.40, an increase of 38.54% year-over-year[4] - Net profit attributable to shareholders was ¥35,571,307.85, up 152.21% compared to the same period last year[4] - Basic earnings per share for Q3 2023 were ¥0.30, reflecting a 150.00% increase year-over-year[4] - Operating profit for Q3 2023 was ¥82,776,952.20, significantly up from ¥32,307,181.83 in the same period last year, marking a growth of 156.5%[24] - Net profit for Q3 2023 was ¥72,653,569.09, compared to ¥29,590,893.31 in Q3 2022, representing a year-over-year increase of 144.5%[24] - The company reported a 176.34% increase in net profit after deducting non-recurring gains and losses, totaling ¥35,070,956.58 for Q3 2023[4] Assets and Liabilities - Total assets as of September 30, 2023, amounted to ¥2,253,149,638.15, representing an 11.00% increase from the end of the previous year[4] - Total assets as of Q3 2023 amounted to ¥2,253,149,638.15, up from ¥2,029,945,060.50 at the end of Q3 2022, reflecting a growth of 11.0%[21] - Total liabilities increased to ¥1,027,923,164.09 in Q3 2023 from ¥869,812,155.53 in Q3 2022, indicating a rise of 18.2%[21] - The total liabilities decreased by 36.47% to ¥53,142,350.00, mainly due to the repayment of long-term borrowings[11] - The company's equity attributable to shareholders increased by 5.61% to ¥1,225,226,474.06 compared to the end of the previous year[4] - The total equity attributable to shareholders of the parent company rose to ¥1,225,226,474.06 from ¥1,160,132,904.97, an increase of 5.6% year-over-year[21] Cash Flow - Cash flow from operating activities for the year-to-date reached ¥180,506,949.21, a significant increase of 826.71%[4] - Cash inflow from operating activities totaled approximately ¥738.58 million, up from ¥585.91 million year-on-year, marking a 26% increase[25] - Net cash flow from operating activities was ¥180.51 million, a significant recovery from a net outflow of ¥24.84 million in the previous year[25] - Cash inflow from investment activities was approximately ¥497.43 million, compared to ¥80.87 million in the same period last year, indicating a substantial increase[26] - Net cash flow from investment activities was -¥197.35 million, an improvement from -¥390.55 million year-on-year[26] - Cash inflow from financing activities was ¥150 million, consistent with the previous year[26] - Net cash flow from financing activities decreased to ¥49.62 million from ¥120.45 million year-on-year[26] Income and Expenses - Investment income surged by 251.32% to ¥1,809,409.43, primarily due to increased returns from bank wealth management products[9] - The company reported a significant increase in income tax expenses, which rose by 302.45% to ¥9,912,815.76, reflecting higher total profits[9] - The company's financial expenses improved by 41.21%, reducing to -¥11,323,246.67, attributed to decreased exchange losses[9] - The company’s other income decreased by 31.82% to ¥2,752,193.73, mainly due to a reduction in government subsidies received[9] - The company’s asset impairment losses increased by 184.28% to -¥15,699,072.75, primarily due to higher provisions for asset impairments[9] - Research and development expenses for Q3 2023 were ¥28,647,208.15, slightly down from ¥28,750,267.53 in Q3 2022, indicating a focus on cost management[22] Shareholder Information - Total number of common shareholders at the end of the reporting period is 14,233[14] - The largest shareholder, Hainan Jiangheng Industrial Investment Co., Ltd., holds 33.89% of shares, totaling 40,662,000 shares, with 19,466,200 shares pledged[14] - The total number of preferred shareholders at the end of the reporting period is not applicable[16] - The company has not disclosed any relationships or agreements among its top shareholders[15] Other Information - The company experienced a 42.33% decrease in trading financial assets, primarily due to reduced financial product purchases during the period[8] - The company’s cash and cash equivalents as of September 30, 2023, amount to ¥425,973,695.72, an increase from ¥387,246,958.74 at the beginning of the year[19] - Accounts receivable increased to ¥171,350,040.81 from ¥162,863,709.09 at the beginning of the year[19] - Inventory decreased slightly to ¥157,880,777.99 from ¥161,081,617.61 at the beginning of the year[19] - The total current assets as of September 30, 2023, are ¥883,923,727.31, down from ¥887,890,987.67 at the beginning of the year[19] - The company’s subsidiary, Qingdao Yingpais Health Industry Co., Ltd., was fully deregistered on July 27, 2023[17] - The company is currently involved in a labor arbitration case with a former employee, with a potential liability of ¥102,200[16] - The company did not report any new product launches or technological advancements during the quarter[27] - The third quarter report was not audited, indicating that the figures presented are preliminary[27]